Liuzhou nitidum Inc. originated in 1941, established the Asian soap factory five small, private soap factory; public-private partnership formed in 1956 by the "soap factory in Liuzhou"; soap factory in 1963, renamed "Liuzhou Daily Chemical Factory "; toothpaste plant in 1978, its separation, a separate form," Liuzhou toothpaste factory "; in 1980 built a new factory; transformed into joint-stock companies in 1994; in 2004 to be the first listed company. Our main products are: oral care products, herbal medicine, toilet paper products, cleaning skin care products, hotel supplies, wood products and fine chemicals; addition the company also engaged in some capital management and real estate business.
Company's leading products, "both sides of needle Chinese toothpaste" brand in China, and was recognized as "national quality standards for model products", "National Customer Satisfaction Product", two needle mark for the Chinese famous trademark.
Company twice won the National Labor Award, the leaders of the two companies won the National Labor Medal, has won the national light industrial systems, Guangxi Zhuang Autonomous Region title of model workers.
Company is Oral hygiene Care Products Industry Association unit, is the industry's first through the ISO9001 international quality system certification of enterprises, is also currently the only toothpaste approved the establishment of post-doctoral research station enterprise, and has completed a "double analgesia, anti-inflammatory and hemostatic Research and application of active ingredients, "the research.
The company has imported from Germany, the United States, Italy, Switzerland and other countries the introduction of modern production lines. At present, the company has an annual output of 600 million toothpaste, sanitary napkins 500 million, soap production capacity of 150 million. Invested 123 million yuan of new tooth cleaning paste project has been completed, the company produced the feed toothpaste, cream manufacturing and bottling process and equipment has been solid in the world advanced level. Kang Pharmaceutical Company subsidiary billion company successfully through national GMP certification, and supporting advanced pharmaceutical technology and equipment to produce high-quality 150 of Chinese and Western medicines, which Cang rhinitis films and so on 11 kinds of geese well-known pharmaceutical company the exclusive intellectual property rights. Our products sell well in China provinces, municipalities and autonomous regions and Hong Kong and Macao Special Administrative Region, and exported to North America, Western Europe, South Asia, Africa and other countries.
2004, the company invested in new hotels in Yangzhou, Jiangsu products companies in the melt water, the construction of Guangxi and the South drugs Bamboo Wood Products Factory GAP planting base. In 2005, the company's full acquisition and restructuring of Anhui herb toothpaste company. Currently, the project has been fully operational business, and has become the company's new economic growth point.
2005, the sides of needle toothpaste after re-evaluation, once again won the "China Top Brand" title, and won the "China Top Ten most popular public national brand," company chairman Liang Yingqi was awarded "China Top Ten leading independent brand construction People, "the honorary title, the company won the" model of collective national unity and progress, "the honorary title, was named China's chemical industry enterprises" credit? reputation AAA "enterprise.
2006, the sides of needle toothpaste won the State General Administration of Quality Supervision, Inspection and Quarantine issued a "quality state inspection" title. Chairman Liangying Qi was awarded the Guangxi Zhuang Autonomous Region "technology experts" Honor. In the same year in October, two support pins 80 million standard toothpaste success offline, greeted Chinese Premier Wen Jiabao visits to companies, enterprises and expressed his earnest hope, to bring the kind of care staff.
2007, the company focus on fine chemicals, big day, and the three leading pharmaceutical and healthcare business segments, the implementation of the development strategy of related diversification appropriate, strengthen the competitiveness of the building to the "double needle" to build a home business side banner, sustained returns to shareholders, to realize maximum value.
0 komentar:
Posting Komentar